Vyriad

Developer of oncolytic-virus-based immunotherapies for cancer treatment

placeRochester, Minnesota, United States calendar_todayFounded 2016 groups37 employees language vyriad.com

Social engagement

Social engagement: 5K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Array, Southeast Minnesota Capital Fund, Rochester Area Economic Development, Mayo Clinic Ventures.

Investor typeCountShare
Venture capital111%
Private equity111%
Other / undisclosed778%

Hiring activity

Hires periodically

6 roles tracked across 3 of the last 12 months

8 Feb 2026 · Research Associate · Rochester

1 Feb 2026 · Compliance Officer · Rochester

Based on job postings tracked across public sources.

Recent activity

23 Jun 2026
Leadership hire
President
21 May 2026
Event
ASGCT 2026
12 May 2026
Event
American Society of Gene & Cell Therapy 2026
Coming soon